Adenoviral vaccines are widely used. We need to know why some people get deadly blood clots.
Academic rigor, journalistic flair
Articles on Adenovirus vaccine
Displaying all articles
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.
There’s not enough evidence yet to support the AstraZeneca CEO’s statement. But it is theoretically plausible.
Viral vectors are modified viruses that trigger an immune response without causing infection. The vector that’s used in several COVID-19 vaccines was created decades ago by Canadian Frank Graham.
What kind of vaccine is Sputnik V, how does it work, and what data are we missing?
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
Top contributors
-
Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Distinguished University Professor, Department of Pathology and Molecular Medicine, McMaster University
-
Postdoctoral Fellow of Pharmaceutical Science, University of Colorado Anschutz Medical Campus
-
Professor of Internal Medicine, Oklahoma State University
-
Haematology Registrar and Clinical Research Fellow, University of Birmingham
-
Professor of Medical Microbiology, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney
-
Professor of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus
-
Lecturer, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney
-
Associate Professor of Biology, Rochester Institute of Technology
-
Postdoctoral Research Fellow, Institute of Cardiovascular Sciences, University of Birmingham
